Marc Beer Renovia is Aegerion Pharmaceuticals’ former Chief Executive Officer, a medical technology company. In the recent past, he was able to raise $42 million, $10 million in venture debt and $32 million in Series B round, which was channeled towards funding women’s health startup, Renovia Inc., a biopharmaceutical company which develops creative diagnostic and therapeutic equipment for treating diverse pelvic floor disorders. The company was able to develop various new products for treating pelvic floor disorders.
Being a co-founder, chief executive officer and chairman of RenoviaInc, Marc Beer Renovia is a part-time manager with above 25 years of development experience and commercialization of biotechnology and device industries. He became a chief executive officer of Via Cell in the year 2000, a biotechnology industry that focuses on the development, the collection of blood stems cells, and preservation of umbilical cord. During his tenure in the firm, employees grew to more than 300 in number due to an increase in demand for his business.
Apart from being Good Start Genetics Compensation Committee founding chairman, he is also a member and a committee of Minerva Neurosciences Inc Audit Committee. A call that was made to him by a 70-year-old gynecologist who for the last 35 years been doing pelvic floor surgery and was trying to find how he could assist women to evade surgery is what gave him the idea of forming the company. The gynecologist, by the name Dr. Ray Iglesias, dedicated about his last ten years to come up with innovative ways which he could keep patients out of the theatre made him look for Marc Beer Renovia.
Dr. Ray Iglesias’ vision to improve the pelvic disorder treatment coupled with vast knowledge relating to pelvic floor disorders enabled Marc Beer Renovia to develop innovative ways of treating the disorders without women necessarily undergoing surgery. They focused on coming up with innovative products that enable patients to reclaim pelvic floor muscle strength. Food and Drug Administration approved their first product in April 2018.
His venture in finding innovative ways of treating pelvic floor disorders has seen the diagnosis and successful treatment of pelvic floor greatly improve the lives of several women since it was cost effective. The innovative sensor technology that he developed enabled the visualization of real-time treatment of weakened pelvic floor muscles.
He attributes his success in health care to put in place the right organizational structure, acquiring manpower with the right set of skills in the health sector and having key leadership teams. His dynamic leadership in business made him originator of applicable solutions that fulfill urgent issues. This enabled the company to remain on course in making right decisions on resource allocation and remain focused towards achieving long term and short term visions. Learn more: https://www.crunchbase.com/person/marc-beer